Analyst firms · H.C. Wainwright · REGN
H.C. Wainwright REGN price target and rating history
Regeneron Pharmaceuticals Inc. (REGN) · Health Care
H.C. Wainwright rates Regeneron Pharmaceuticals Inc. (REGN) Buy with a $844 price target, as of its latest action on Nov 5, 2021. It has published 5 rating actions on REGN since June 2021, including 0 upgrades and 0 downgrades. Across 9 firms with a REGN price target in the last 12 months, the median target is $798.
- Current rating
- Buy
- Price target
- $844
- Median target, all firms
- $798
- Actions on REGN
- 5
H.C. Wainwright price target on REGN
Every H.C. Wainwright rating on REGN
- Nov 5, 2021
- Oct 22, 2021
- Sep 15, 2021
- Aug 2, 2021
- Jun 29, 2021
How other firms rate REGN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Buy | $850 | Oct 1, 2026 |
| Citigroup | Neutral | $700 | May 18, 2026 |
| Leerink Partners | Market Perform | $641 | May 18, 2026 |
| Piper Sandler | Overweight | $875 | Mar 31, 2026 |
| Barclays | Overweight | $923 | Mar 6, 2026 |
| BofA Securities | Buy | $860 | Jan 7, 2026 |
| Morgan Stanley | Equal-Weight | $767 | Dec 3, 2025 |
| Truist Securities | Buy | $798 | Nov 24, 2025 |
| HSBC | Buy | $255 | Nov 24, 2025 |
Questions about H.C. Wainwright and REGN
- What is H.C. Wainwright's price target for REGN?
- H.C. Wainwright's latest stated price target for Regeneron Pharmaceuticals Inc. (REGN) is $844, from its action on Nov 5, 2021.
- What is H.C. Wainwright's rating on REGN?
- H.C. Wainwright rates REGN Buy, a bullish rating, as of Nov 5, 2021.
- When did H.C. Wainwright last change its view on REGN?
- On Nov 5, 2021, H.C. Wainwright raises its price target to $844 from $842, keeps Buy.
- How does H.C. Wainwright's REGN target compare with other analysts?
- Across 9 firms with a REGN price target in the last 12 months, the median target is $798.
More REGN rating histories
- Citigroup3
- Leerink Partners9
- BofA Securities3
- Morgan Stanley7
- Truist Securities3
- Bernstein3
- Raymond James3
- Oppenheimer3
- Jefferies3
- The Benchmark Company3
All H.C. Wainwright ratingsREGN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.